Clinical Trials

  • Principal Investigator:

    Elana J. Bernstein, MD, MSc
    The purpose of this study is to find out whether a drug called iloprost is safe to use in people with systemic sclerosis (SSc) (Raynaud's phenomenon), and whether it may help decrease symptomatic digital ischemic episodes (episodes in the fingers).
  • Principal Investigator:

    Elana J. Bernstein, MD, MSc
    The purpose of this study is to develop a cohort of patients with early scleroderma and to collect data on clinical outcomes, radiological tests, laboratory tests, and to obtain biological specimens for testing.
  • Principal Investigator:

    Elana J. Bernstein, MD, MSc
    This research is being done to determine how variations in genes may explain the different risk to develop scleroderma (or CREST) seen in African American patients compared to other populations. People who are African American with scleroderma (or CREST) may join. This research involves a blood draw and physical exams.
  • Principal Investigator:

    Joan Marie Bathon, MD
    We are doing a research study to learn more about why people with rheumatoid arthritis (RA) are prone to heart disease. We are recruiting patients diagnosed with Rheumatoid Arthritis without a personal history of heart disease. This study involves one initial full visit as described below, and a brief follow up visit that will take place approximately 2 or more years later. We would incorporate questionnaires, fasting blood tests, 3D-Echocardiogram, PET-CT scan with a cardiac stress test. The 3D-Echocardiogram, blood tests, questionnaires, and a quick CT-scan would be done 3 years later. With...